➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Baxter
McKesson
Merck
Dow

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for meperidine hydrochloride

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Bulk Pharmaceutical API Sources for meperidine hydrochloride

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich   Start Trial M3142_SIGMA   Start Trial
NovoSeek   Start Trial 5750   Start Trial
AAA Chemistry   Start Trial AR-1J2693   Start Trial
ABI Chem   Start Trial AC1L1L1Z   Start Trial
ABI Chem   Start Trial AC1Q64P9   Start Trial
ChemMol   Start Trial 49417168   Start Trial
Chembase.cn   Start Trial 132036   Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.